A new report details how Donald Trump's family has amassed a vast cryptocurrency portfolio, coinciding with a regulatory pullback by the SEC and DOJ. The moves raise questions about conflicts of interest as a Trump-backed venture seeks federal banking approval.
Verizon shares surged nearly 12% after quarterly results and guidance exceeded expectations, highlighting robust subscriber gains and a massive new share repurchase program aimed at rewarding investors.
Altria Group names CFO Salvatore Mancuso as its incoming CEO, accelerating its smoke-free transition while taking a massive impairment charge on past investments, signaling a sharp strategic reassessment.
Wells Fargo updates its long-term valuation for American Electric Power (AEP), raising its price target to $140, as the utility secures a major fuel cell investment and a 20-year power purchase agreement for a new Wyoming facility.
Wix.com Ltd. has launched a major share repurchase program as its stock trades near multi-year lows. While analysts have trimmed price targets, many maintain bullish ratings, citing significant upside potential and a more resilient outlook for SaaS companies in the face of AI disruption.
In a striking pivot, crypto giant Tether is now stockpiling over a ton of gold weekly in a fortified Swiss vault—a move echoing crypto's early days but signaling a profound shift towards traditional safe-havens as digital assets falter.
Senator Lindsey Graham has stalled a bipartisan funding deal to avert a shutdown, demanding the restoration of a controversial provision allowing lawmakers to sue the Justice Department for damages—a move critics decry as a self-serving scheme.
Panama's Supreme Court has declared CK Hutchison's concession to operate the Balboa and Cristóbal ports unconstitutional, derailing a major sale and placing APM Terminals in temporary control. The ruling intensifies geopolitical tensions over control of the strategic Panama Canal.
Major music publishers have launched a massive copyright infringement lawsuit against AI company Anthropic, alleging its Claude AI was trained on a dataset of over 20,000 pirated songs, in a case that could redefine the rules for AI development.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
A new analysis from the New York Independent System Operator (NYISO) links volatile natural gas markets directly to rising consumer electricity costs. With gas fueling half of New York's power generation, increased demand and export levels are set to keep pressure on household budgets.
In a strategic move to reduce reliance on foreign tech giants, Japan launches a national AI initiative, combining SoftBank's leadership with substantial government backing to develop a domestic foundational model.
Microsoft shares suffered their steepest single-day drop in over three years after Azure cloud growth narrowly missed estimates, revealing the complex trade-offs between fueling internal AI projects and meeting soaring external demand.
Under new leadership, Verizon posts its best subscriber growth in years, outlines a massive cost-cutting plan, and signals a strategic pivot towards customer retention and convergence, backed by the completed Frontier acquisition.
UBS initiates coverage on Rithm Capital with a Buy rating and a $16 price target, highlighting the REIT's aggressive acquisition strategy—including the purchases of Paramount Group and Crestline—as a key driver for expanding its asset management footprint and unlocking shareholder value.
After a three-year suspension due to insurgent violence, TotalEnergies and Mozambique have agreed to restart one of Africa's largest natural gas developments, raising hopes for economic transformation amid lingering risks.
China Life Insurance announces governance changes and a major investment partnership, highlighting a strategic pivot towards long-term, related-party investments amidst evolving regulatory landscapes in Asia's insurance sector.
In a landmark deal, AstraZeneca has licensed a suite of next-generation weight-loss drugs from China's CSPC, aiming to challenge the dominance of Lilly and Novo Nordisk with longer-acting monthly injectables.
The German sportswear giant reports preliminary figures showing robust growth for the Adidas brand, driven by double-digit expansion across all regions, and unveils a major capital return program to shareholders.
